DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Cho IR, Kang H, Jo JH. et al.
FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study.
World J Gastrointest Oncol 2020;
12: 182-194
DOI: 10.4251/wjgo.v12.i2.182.
We do not assume any responsibility for the contents of the web pages of other providers.